Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face.
Dudas
Marek
M
Developmental Biology Program at the Saban Research Institute of Children's Hospital Los Angeles, Los Angeles, California 90027, USA.
Kaartinen
Vesa
V
D029404:Activin Receptors / Q000235:genetics / Q000378:metabolism; D028341:Activins / Q000378:metabolism; D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000378:metabolism*; D019465:Craniofacial Abnormalities / Q000235:genetics / Q000378:metabolism; D047108:Embryonic Development / Q000502:physiology*; D004627:Embryonic Induction; D005145:Face / Q000033:anatomy & histology / Q000196:embryology*; D006133:Growth Substances / Q000378:metabolism*; D006257:Head / Q000033:anatomy & histology / Q000196:embryology*; D007265:Inhibins / Q000378:metabolism; D008024:Ligands; D051379:Mice; D009432:Neural Crest / Q000166:cytology / Q000502:physiology; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D019485:Bone Morphogenetic Proteins; D006133:Growth Substances; D008024:Ligands; D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta; D028341:Activins; D007265:Inhibins; D029404:Activin Receptors